CSHL Fellow Jason Sheltzer wins innovation award January 25, 2019 CSHL Fellow Jason Sheltzer wins the Damon Runyon-Rachleff Innovation Award for his work on cancer.
The year of CRISPR December 26, 2018 A look at the various labs across CSHL that utilize CRISPR in their research, and the groundbreaking discoveries they help uncover.
Taking uncertainty out of cancer prognosis December 11, 2018 CSHL Fellow Jason Sheltzer has analyzed nearly 20,000 cancer patient histories and genetic data to take the guesswork out of prognosis.
The cancer answer that wasn’t March 15, 2018 We look at the "reproducibility crisis" in science, with a cancer researcher discovering something he didn't expect while experimenting with MELK
Science self-corrects: cancer gene does not pass reproducibility test February 13, 2018 CSHL Fellow Jason Sheltzer and his research team use CRISPR to discover that MELK is not actually involved in cancer.
What a real-life science test looks like March 24, 2017 By revealing evidence that contradicts the rationale for a new cancer drug, a pair of student scientists learns firsthand that when you do science.
Relationship between incorrect chromosome number and cancer is reassessed after surprising experiments January 12, 2017 Pre-malignant aneuploid cells grew more slowly and formed smaller tumors than comparable cells with normal chromosome number, CSHL researchers found.
CSHL Fellow wins 2015 NIH Early Independence Award for cancer research October 6, 2015 CSHL Lab Fellow Jason Sheltzer won the 2015 Early Independence Award from the National Institutes of Health High Risk, High Reward Research Program
